Sign inGet started

GRIMALDI CLAUDIA

Insider CIK 1745853 · IGC Vice President and PFO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
IGC IGC Pharma, Inc. G Gift2026-09-252026-09-29150,000— $03,271,092SEC↗
IGC IGC Pharma, Inc. G Gift2026-09-252026-09-29150,000— $03,271,092SEC↗
IGC IGC Pharma, Inc. A Award2026-06-302026-07-012,048,378$0.27 $553.1K3,421,092SEC↗
IGC IGC Pharma, Inc. M Exercise deriv2026-04-012026-04-06138,462— $0221,538SEC↗
IGC IGC Pharma, Inc. M Exercise deriv2026-04-012026-04-06100,000— $00SEC↗
IGC IGC Pharma, Inc. M Exercise2026-04-012026-04-06100,000— $01,234,252SEC↗
IGC IGC Pharma, Inc. M Exercise2026-04-012026-04-06138,462$0.26 $36.0K1,372,714SEC↗
IGC IGC Pharma, Inc. A Award deriv2025-10-172025-10-211,000,000— $01,000,000SEC↗
IGC IGC Pharma, Inc. A Award deriv2025-10-172025-10-21500,000— $0500,000SEC↗
IGC IGC Pharma, Inc. G Gift2025-10-172025-10-2150,000— $01,134,252SEC↗
IGC IGC Pharma, Inc. M Exercise deriv2024-03-132024-03-1583,333— $00SEC↗
IGC IGC Pharma, Inc. M Exercise deriv2024-03-132024-03-1558,334— $058,332SEC↗
IGC IGC Pharma, Inc. M Exercise deriv2024-03-132024-03-15100,000— $0200,000SEC↗
IGC IGC Pharma, Inc. M Exercise deriv2024-03-132024-03-1595,000— $0285,000SEC↗
IGC IGC Pharma, Inc. A Award deriv2024-03-132024-03-15360,000— $0360,000SEC↗
IGC IGC Pharma, Inc. A Award deriv2024-03-132024-03-15550,000— $0550,000SEC↗
IGC IGC Pharma, Inc. M Exercise2024-03-132024-03-1558,333— $0842,154SEC↗
IGC IGC Pharma, Inc. M Exercise2024-03-132024-03-15100,000— $0942,154SEC↗
IGC IGC Pharma, Inc. M Exercise2024-03-132024-03-1595,000— $01,037,154SEC↗
IGC IGC Pharma, Inc. M Exercise2024-03-132024-03-1583,333— $0783,821SEC↗
IGC IGC Pharma, Inc. A Award deriv2023-06-202023-06-28300,000— $0300,000SEC↗
IGC IGC Pharma, Inc. A Award deriv2023-06-202023-06-28380,000— $0380,000SEC↗
IGC IGC Pharma, Inc. M Exercise deriv2023-03-312023-06-2858,334— $0116,666SEC↗
IGC IGC Pharma, Inc. M Exercise deriv2023-03-312023-06-2883,333— $083,833SEC↗
IGC IGC Pharma, Inc. M Exercise2023-03-312023-06-2858,334— $0700,488SEC↗
IGC IGC Pharma, Inc. M Exercise2023-03-312023-06-2883,333— $0642,154SEC↗
IGC India Globalization Capita M Exercise deriv2022-06-012022-06-289,375— $0279,166SEC↗
IGC India Globalization Capita M Exercise2022-06-012022-06-289,375— $0558,821SEC↗
IGC India Globalization Capita M Exercise deriv2022-05-312022-06-2828,125— $0288,541SEC↗
IGC India Globalization Capita M Exercise2022-05-312022-06-2828,125— $0549,446SEC↗
IGC IGC Pharma, Inc. A Award deriv2022-05-252023-06-28175,000— $0175,000SEC↗
IGC India Globalization Capita M Exercise deriv2022-03-212022-06-2883,334— $0316,666SEC↗
IGC India Globalization Capita M Exercise2022-03-212022-06-2883,334— $0521,321SEC↗
IGC India Globalization Capita A Award deriv2021-12-202021-12-23150,000— $0400,000SEC↗
IGC India Globalization Capita A Award deriv2021-12-202021-12-23250,000— $0250,000SEC↗
IGC India Globalization Capita A Award2021-12-202021-12-23250,000— $0437,987SEC↗
IGC India Globalization Capita A Award2019-06-112019-06-12300,000— $0852,987SEC↗
IGC India Globalization Capita S Sale2018-08-302018-08-31116,020$2.00 $232.0K552,987SEC↗
IGC India Globalization Capita A Award2018-08-292018-08-2975,000— $0669,007SEC↗
IGC India Globalization Capita S Sale2018-08-272018-08-2950,000$1.10 $55.0K594,007SEC↗